{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:22:26Z","timestamp":1782804146518,"version":"3.54.5"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jdin.2024.08.010","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T23:06:58Z","timestamp":1725750418000},"page":"141-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Chronic disease associated with bullous pemphigoid risk: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"17","author":[{"given":"Noppachai","family":"Siranart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanisa","family":"Chumpangern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somkiat","family":"Phutinart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5647-346X","authenticated-orcid":false,"given":"Patavee","family":"Pajareya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinrada","family":"Worapongpaiboon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanissara","family":"Winson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charat","family":"Thongprayoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wisit","family":"Cheungpasitporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdin.2024.08.010_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.jdin.2024.08.010_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/1523-1747.ep12616580","article-title":"Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180","volume":"99","author":"Giudice","year":"1992","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.08.010_bib3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1067\/mjd.2001.117518","article-title":"Immunofluorescence in dermatology","volume":"45","author":"Mutasim","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.08.010_bib4","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI113803","article-title":"Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies","volume":"82","author":"Stanley","year":"1988","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jdin.2024.08.010_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0190-9622(89)70054-2","article-title":"Direct immunofluorescence in bullous pemphigoid: effects of extent and location of lesions","volume":"20","author":"Weigand","year":"1989","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jdin.2024.08.010_bib6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3390\/biom10101432","article-title":"Bullous pemphigoid: trigger and predisposing factors","volume":"10","author":"Moro","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.jdin.2024.08.010_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0272-6386(89)80076-9","article-title":"Bullous pemphigoid-associated nephropathy: report of two cases and review of the literature","volume":"14","author":"Ross","year":"1989","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.jdin.2024.08.010_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/ajd.12764","article-title":"Association between bullous pemphigoid and malignancy: a meta-analysis","volume":"59","author":"Lucariello","year":"2018","journal-title":"Australas J Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.08.010_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/bjd.20759","article-title":"Cause-specific mortality in people with bullous pemphigoid and pemphigus vulgaris: a systematic review and meta-analysis","volume":"186","author":"Hasanaj","year":"2022","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2024.08.010_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00403-017-1736-1","article-title":"Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis","volume":"309","author":"Liu","year":"2017","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.jdin.2024.08.010_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5021\/ad.2018.30.1.13","article-title":"Mortality and comorbidity profiles of patients with bullous pemphigoid in Korea","volume":"30","author":"Jeon","year":"2018","journal-title":"Ann Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.08.010_bib12","first-page":"81","article-title":"The association between bullous pemphigoid and neurological disorders in a selected Malaysian population","volume":"70","author":"Kwan","year":"2015","journal-title":"Med J Malaysia"},{"issue":"3","key":"10.1016\/j.jdin.2024.08.010_bib13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: a population-based case-control study","volume":"131","author":"Langan","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2024.08.010_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00403-020-02100-2","article-title":"Association of bullous pemphigoid and comorbid health conditions: a case-control study","volume":"313","author":"Lee","year":"2021","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1016\/j.jdin.2024.08.010_bib15","first-page":"798","article-title":"Comorbid diseases among bullous pemphigoid patients in Germany: new insights from a case-control study","volume":"20","author":"Martin","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"10.1016\/j.jdin.2024.08.010_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/bjd.14821","article-title":"Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A","volume":"176","author":"Ren","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.08.010_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40257-017-0257-1","article-title":"The inpatient burden of autoimmune blistering disease in US children: analysis of nationwide inpatient sample data","volume":"18","author":"Ren","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"10.1016\/j.jdin.2024.08.010_bib18","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/jdv.14312","article-title":"Multimorbidity in bullous pemphigoid: a case\u2013control analysis of bullous pemphigoid patients with age- and gender-matched controls","volume":"31","author":"Sim","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jdin.2024.08.010_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00403-022-02372-w","article-title":"Association between bullous pemphigoid and atopic dermatitis: a population-based case\u2013control study in Taiwan","volume":"315","author":"Wu","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.jdin.2024.08.010_bib20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: a prospective case-control study","volume":"131","author":"Bastuji-Garin","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.08.010_bib21","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jaad.2014.07.052","article-title":"A population-based study of the association between bullous pemphigoid and neurologic disorders","volume":"71","author":"Brick","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jdin.2024.08.010_bib22","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ad.2014.04.013","article-title":"Association between bullous pemphigoid and neurologic diseases: a case-control study","volume":"105","author":"Casas-de-la-Asunci\u00f3n","year":"2014","journal-title":"Actas Dermosifiliogr"},{"issue":"3","key":"10.1016\/j.jdin.2024.08.010_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2133.2011.10386.x","article-title":"Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study","volume":"165","author":"Chen","year":"2011","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.08.010_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/0378-6323.191132","article-title":"Neurological diseases and bullous pemphigoid: a case-control study in Iranian patients","volume":"83","author":"Daneshpazhooh","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.jdin.2024.08.010_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1684\/ejd.2010.0805","article-title":"Bullous pemphigoid and internal diseases - a case-control study","volume":"20","author":"Jedlickova","year":"2010","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2024.08.010_bib26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.17219\/acem\/90922","article-title":"The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: case-control study in a specialized Polish center","volume":"28","author":"Kali\u0144ska-Bienias","year":"2019","journal-title":"Adv Clin Exp Med"},{"issue":"6","key":"10.1016\/j.jdin.2024.08.010_bib27","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/bjd.15405","article-title":"Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid","volume":"176","author":"Kibsgaard","year":"2017","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2024.08.010_bib28","article-title":"Comorbidities of bullous pemphigoid: a single-center retrospective case-control study from Turkey","volume":"34","author":"K\u0131l\u0131\u00e7Sayar","year":"2021","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.jdin.2024.08.010_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40257-017-0293-x","article-title":"Association between inflammatory skin disease and cardiovascular and cerebrovascular co-morbidities in US adults: analysis of nationwide inpatient sample data","volume":"18","author":"Kwa","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.08.010_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1684\/ejd.2018.3243","article-title":"Comorbidities of bullous pemphigoid in a Finnish cohort","volume":"28","author":"Pankakoski","year":"2018","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2024.08.010_bib31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jdv.15444","article-title":"Neurological disorders are associated with bullous pemphigoid","volume":"33","author":"Papakonstantinou","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdin.2024.08.010_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4103\/0378-6323.198451","article-title":"Bullous pemphigoid and antecedent neurological diseases: an association with dementia","volume":"83","author":"Phuan","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"8","key":"10.1016\/j.jdin.2024.08.010_bib33","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archderm.1975.01630200051003","article-title":"Bullous pemphigoid and associated malignant neoplasms","volume":"111","author":"Stone","year":"1975","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.08.010_bib34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1590\/abd1806-4841.20142516","article-title":"Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients","volume":"89","author":"Teixeira","year":"2014","journal-title":"An Bras Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2024.08.010_bib35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2133.1990.tb01447.x","article-title":"The association of bullous pemphigoid and malignant disease: a case control study","volume":"123","author":"Venning","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdin.2024.08.010_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221130707","article-title":"Relationship between bullous pemphigoid and metabolic syndrome: a 12-year case-control study conducted in China","volume":"13","author":"Zhang","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"issue":"3","key":"10.1016\/j.jdin.2024.08.010_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/bjd.17197","article-title":"Cancer is not a risk factor for bullous pemphigoid: 10-year population-based cohort study","volume":"180","author":"Chen","year":"2019","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jdin.2024.08.010_bib38","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/jdv.18106","article-title":"Association between sodium-glucose co-transporter 2 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: a nationwide population-based cohort study","volume":"36","author":"Ma","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.jdin.2024.08.010_bib39","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/1346-8138.16948","article-title":"Risk of bullous pemphigoid and pemphigus in patients on chronic dialysis: A nationwide population-based cohort study","volume":"50","author":"Tang","year":"2023","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2024.08.010_bib40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40257-019-00494-y","article-title":"Neurological cancer is a risk factor for bullous pemphigoid: 11-year population-based cohort study","volume":"21","author":"Wu","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jdin.2024.08.010_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108546","article-title":"Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A population-based cohort study","volume":"171","author":"Wu","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"10.1016\/j.jdin.2024.08.010_bib42","first-page":"1480","article-title":"Association between chronic kidney disease and risk of bullous pemphigoid: a nationwide population-based cohort study","volume":"21","author":"Yu","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"10.1016\/j.jdin.2024.08.010_bib43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/1346-8138.15685","article-title":"Risk of solid\u00a0malignancies in bullous pemphigoid: A large-scale population-based cohort study","volume":"48","author":"Kridin","year":"2021","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.08.010_bib44","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/bjd.12806","article-title":"Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre","volume":"170","author":"Cai","year":"2014","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2024.08.010_bib45","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/jdv.12065","article-title":"Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre","volume":"28","author":"Gual","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdin.2024.08.010_bib46","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaad.2014.05.006","article-title":"Mortality of patients with bullous pemphigoid in Korea","volume":"71","author":"Lee","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.08.010_bib47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000516632","article-title":"Association of immunosuppressants with mortality of patients with bullous pemphigoid: a nationwide population-based cohort study","volume":"238","author":"Wu","year":"2022","journal-title":"Dermatology"},{"issue":"43","key":"10.1016\/j.jdin.2024.08.010_bib48","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022850","article-title":"Clinical characteristics, mortality, and prognostic factors for bullous pemphigoid in a Thai population","volume":"99","author":"Amonchaisakda","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.jdin.2024.08.010_bib49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000345625","article-title":"Mortality rate in bullous pemphigoid: A retrospective monocentric cohort study","volume":"225","author":"Cort\u00e9s","year":"2013","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.jdin.2024.08.010_bib50","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2133.2011.10413.x","article-title":"Mortality of bullous pemphigoid in Switzerland: a prospective study","volume":"165","author":"Cort\u00e9s","year":"2011","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.08.010_bib51","first-page":"758","article-title":"Risk of death in bullous pemphigoid: a retrospective database study in Finland","volume":"96","author":"F\u00f6rsti","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.jdin.2024.08.010_bib52","first-page":"263","article-title":"Association between bullous pemphigoid and internal diseases","volume":"11","author":"Li","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"issue":"7","key":"10.1016\/j.jdin.2024.08.010_bib53","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/jdv.16363","article-title":"Anti-BP180 autoantibody levels at diagnosis correlate with 1-year mortality rates in patients with bullous pemphigoid","volume":"34","author":"Monshi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jdin.2024.08.010_bib54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.25259\/IJDVL_705_2021","article-title":"Survival and prognostic factors in bullous pemphigoid: a retrospective cohort study","volume":"89","author":"Papara","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"10.1016\/j.jdin.2024.08.010_bib55","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2024.08.010_bib56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00403-018-1875-z","article-title":"Mortality and risk factors among Israeli bullous pemphigoid patients","volume":"311","author":"Rozenblat","year":"2019","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.jdin.2024.08.010_bib57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamadermatol.2021.5125","article-title":"Risk of all-cause mortality, cardiovascular disease mortality, and cancer mortality in patients with bullous pemphigoid","volume":"158","author":"Shen","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2024.08.010_bib58","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/ajd.13852","article-title":"Mortality and prognostic factors of bullous pemphigoid in a Moroccan population","volume":"63","author":"Titou","year":"2022","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2024.08.010_bib59","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1684\/ejd.2012.1906","article-title":"Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study","volume":"23","author":"Zhang","year":"2013","journal-title":"Eur J Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.08.010_bib60","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/ndt\/gfp005","article-title":"End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells","volume":"24","author":"Hendrikx","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.jdin.2024.08.010_bib61","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jaci.2018.03.014","article-title":"Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects","volume":"142","author":"Muramatsu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.jdin.2024.08.010_bib62","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.jdin.2024.08.010_bib63","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jaad.2019.11.018","article-title":"Diabetes mellitus and hyperglycemic complications in bullous pemphigoid","volume":"82","author":"Chai","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.08.010_bib64","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaad.2017.12.038","article-title":"Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: retrospective multicenter case-control study from France and Switzerland","volume":"78","author":"Benzaquen","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2024.08.010_bib65","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjd.13717","article-title":"Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology","volume":"172","author":"Feliciani","year":"2015","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2024.08.010_bib66","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000106574","article-title":"Neurological disorders in patients with bullous pemphigoid","volume":"215","author":"Cordel","year":"2007","journal-title":"Dermatology"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724001378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724001378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T19:43:13Z","timestamp":1748547793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328724001378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":66,"alternative-id":["S2666328724001378"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2024.08.010","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic disease associated with bullous pemphigoid risk: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2024.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}